CORC

在结果中检索

CORC

浏览/检索结果: 共46条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial 期刊论文
LANCET ONCOLOGY, 2019, 卷号: 20, 期号: 6
作者:  Jiang, Zefei;  Li, Wei;  Hu, Xichun;  Zhang, Qingyuan;  Sun, Tao
收藏  |  浏览/下载：28/0  |  提交时间：2019/12/05
Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study 期刊论文
2019, 卷号: 37, 期号: 29, 页码: 2610-2619
作者:  Ma Fei;  Ouyang Quchang;  Li Wei;  Jiang Zefei;  Tong Zhongsheng
收藏  |  浏览/下载：32/0  |  提交时间：2020/01/03
Transformation of Fonsecaea pedrosoi into sclerotic cells links to the refractoriness of experimental chromoblastomycosis in BALB/c mice via a mechanism involving a chitin-induced impairment of IFN-gamma production 期刊论文
PLOS NEGLECTED TROPICAL DISEASES, 2018, 卷号: 12, 期号: 2, 页码: 31
作者:  Dong, Bilin;  Tong, Zhongsheng;  Li, Ruoyu;  Chen, Sharon C. -A.;  Liu, Weihuang
收藏  |  浏览/下载：33/0  |  提交时间：2019/07/03
Transformation of Fonsecaea pedrosoi into sclerotic cells links to the refractoriness of experimental chromoblastomycosis in BALB/c mice via a mechanism involving a chitin-induced impairment of IFN-gamma production 期刊论文
PLOS NEGLECTED TROPICAL DISEASES, 2018, 卷号: 12, 期号: 2, 页码: 31
作者:  Tong, Zhongsheng;  Li, Ruoyu;  Chen, Sharon C. -A.;  Liu, Weihuang;  Liu, Wei
收藏  |  浏览/下载：36/0  |  提交时间：2018/12/29
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 期刊论文
CANCER RESEARCH, 2018, 卷号: 78, 期号: 4
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Transformation of Fonsecaea pedrosoi into sclerotic cells links to the refractoriness of experimental chromoblastomycosis in BALB/c mice via a mechanism involving a chitin-induced impairment of IFN-gamma production 期刊论文
PLOS NEGLECTED TROPICAL DISEASES, 2018, 卷号: 12, 期号: 2
作者:  Dong, Bilin;  Tong, Zhongsheng;  Li, Ruoyu;  Chen, Sharon C. -A.;  Liu, Weihuang
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文
CANCER RESEARCH, 2018-02-01
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 期刊论文
2018, 卷号: 78, 期号: 4
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial 期刊论文
LANCET ONCOLOGY, 2017, 卷号: 18, 期号: 3
作者:  Zhang, Pin;  Sun, Tao;  Zhang, Qingyuan;  Yuan, Zhongyu;  Jiang, Zefei
收藏  |  浏览/下载：19/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace